{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:23:22Z","timestamp":1783646602922,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1016\/j.ygyno.2003.07.002","type":"journal-article","created":{"date-parts":[[2003,10,17]],"date-time":"2003-10-17T13:42:29Z","timestamp":1066398149000},"page":"526-533","source":"Crossref","is-referenced-by-count":80,"title":["Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone"],"prefix":"10.1016","volume":"91","author":[{"given":"A.B","family":"Vereide","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Arnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Straume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M","family":"Maltau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"\u00d8rbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2003.07.002_BIB1","first-page":"33","article-title":"Hormonal therapy for lesions of the endometrium","volume":"13","author":"Gal","year":"1986","journal-title":"Semin oncol"},{"key":"10.1016\/j.ygyno.2003.07.002_BIB2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0002-9378(89)90103-8","article-title":"The biologic significance of cytological atypia in progestogen-treated endometrial hyperplasia","volume":"160","author":"Ferenczy","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2003.07.002_BIB3","first-page":"725","article-title":"Endometrial hyperplasia","volume":"10","author":"Lindahl","year":"1990","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ygyno.2003.07.002_BIB4","first-page":"403","article-title":"Endometrial hyperplasia. Clinico-pathological considerations of a prospective randomised study after abrasio only or high-dose gestagen treatment. Results of 2 years follow-up of 292 patients","volume":"11","author":"Lindahl","year":"1991","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ygyno.2003.07.002_BIB5","series-title":"Gynecologic oncology","first-page":"747","article-title":"Premalignant lesions of the endometrium","author":"Trop\u00e9","year":"1992"},{"key":"10.1016\/j.ygyno.2003.07.002_BIB6","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0029-7844(97)00297-4","article-title":"Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40","volume":"90","author":"Randall","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2003.07.002_BIB7","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1471-0528.1990.tb16240.x","article-title":"Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia","volume":"97","author":"Andersson","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ygyno.2003.07.002_BIB8","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1471-0528.1997.tb11542.x","article-title":"The levonorgestrel intrauterine system in the management of menorrhagia","volume":"104","author":"Barrington","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ygyno.2003.07.002_BIB9","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2265.1982.tb01625.x","article-title":"Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD","volume":"17","author":"Nilsson","year":"1982","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ygyno.2003.07.002_BIB10","first-page":"137","article-title":"Treatment of endometrial hyperplasia with levonorgestrel releasing intrauterine devices","volume":"18","author":"Perino","year":"1987","journal-title":"Acta Eur Fertil"},{"key":"10.1016\/j.ygyno.2003.07.002_BIB11","first-page":"284","article-title":"Levo-norgestrel-nova-T and precancerous lesions of the endometrium","volume":"9","author":"Scarselli","year":"1988","journal-title":"Eur J. Gynaecol Oncol"},{"key":"10.1016\/j.ygyno.2003.07.002_BIB12","first-page":"614","article-title":"Levonorgestrel IUS\u2014treatment for endometrial cystic hyperplasia","volume":"104","author":"Rose","year":"1997","journal-title":"Gynecology case reports"},{"key":"10.1016\/j.ygyno.2003.07.002_BIB13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/path.1711540409","article-title":"Architectural and nuclear morphometrical features together are more important prognosticators in endometrial hyperplasia than nuclear morphometrical features alone","volume":"154","author":"Baak","year":"1988","journal-title":"J. Pathol"},{"key":"10.1016\/j.ygyno.2003.07.002_BIB14","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/00000478-200107000-00012","article-title":"Prospective multicenter evaluation of the morphometric D-score for prediction of the outcome of endometrial hyperplasia","volume":"25","author":"Baak","year":"2001","journal-title":"Am J Surg Path"},{"key":"10.1016\/j.ygyno.2003.07.002_BIB15","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X","article-title":"The behavior of endometrial hyperplasia. A long-term study of \u201cuntreated\u201d hyperplasia in 170 patients","volume":"56","author":"Kurman","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2003.07.002_BIB16","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s004280100503","article-title":"The histological diagnosis of endometrial hyperplasia","volume":"439","author":"Dietel","year":"2001","journal-title":"Virchows Arch"},{"key":"10.1016\/j.ygyno.2003.07.002_BIB17","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/00000478-199808000-00012","article-title":"Reproducibility of the diagnosis of endometrial hyperplasia, and well-differentiated carcinoma","volume":"2","author":"Kendall","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2003.07.002_BIB18","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/00000478-199909000-00014","article-title":"A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens","volume":"23","author":"Bergeron","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2003.07.002_BIB19","unstructured":"Baak JPA, Oort J. The case for quantitative pathology in cancer diagnosis and treatment. In: Manual of quantitative pathology in cancer diagnosis and prognosis. Heidelberg\/New York: Springer; 1991, p. 7\u201318"},{"key":"10.1016\/j.ygyno.2003.07.002_BIB20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0046-8177(94)90175-9","article-title":"Reproducibility of mean nuclear volume and correlation with mean nuclear area in breast cancer","volume":"25","author":"Baak","year":"1994","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ygyno.2003.07.002_BIB21","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/S0002-9378(96)70599-9","article-title":"Use of computerized morphometric analyses of endometrial hyperplasias in the prediction of coexistent cancer","volume":"174","author":"Dunton","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2003.07.002_BIB22","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/jcp.53.9.697","article-title":"Computerized morphometrical analysis in endometrial hyperplasia for the prediction of cancer development. A long term retrospective study from northern Norway","volume":"53","author":"\u00d8rbo","year":"2000","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ygyno.2003.07.002_BIB23","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/(SICI)1096-9896(200003)190:4<462::AID-PATH590>3.0.CO;2-D","article-title":"Endometrial precancer diagnosis by histopathology, clonal analysis and computerized orphometry","volume":"190","author":"Mutter","year":"2000","journal-title":"J Pathol"},{"key":"10.1016\/j.ygyno.2003.07.002_BIB24","first-page":"287","article-title":"Prospective multicenter long-term evaluation of the computerized morphometric D-score to predict the outcome of endometrial hyperplasias","volume":"76","author":"Baak","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2003.07.002_BIB25","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00004347-200210000-00007","article-title":"Apoptosis-related proteins and steroid hormone receptors in normal, hyperplastic, and neoplastic endometrium","volume":"21","author":"Bozdogan","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ygyno.2003.07.002_BIB26","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/bjc.1972.33","article-title":"Apoptosis","volume":"26","author":"Err","year":"1972","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2003.07.002_BIB27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/gyno.2000.5955","article-title":"Apoptosis may be an early event of progestin therapy for endometrial hyperplasia","volume":"79","author":"Amescua","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2003.07.002_BIB28","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1093\/humrep\/16.10.2103","article-title":"Effect of levonorgestrel-releasing intrauterine system on proliferation and apoptosis in the endometrium","volume":"16","author":"Maruo","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ygyno.2003.07.002_BIB29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0010-7824(77)90086-5","article-title":"Biochemical and morphological changes in the human endometrium induced by the progestasert device","volume":"16","author":"Hagenfeldt","year":"1977","journal-title":"Contraception"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825803005031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825803005031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T09:58:09Z","timestamp":1550570289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825803005031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S0090825803005031"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2003.07.002","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}